4 results
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Initiative (PAMI ... - Agents and Dosing ... #Management # ... Pain #Pharmacology ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Ketamine Dosing

#Management #Pain #Pharmacology #Ketamine #Analgesia #Subdissociative #ExcitedDelirium #Doses
Initiative (PAMI ... #Management # ... Pain #Pharmacology ... #Ketamine #Analgesia ... #Table #PAMI
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... This drug class ... #Pharmacology # ... Management #Diabetes ... #DM2 #Endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... to remain stable ... #semaglutide #Diabetes ... #Pharmacology # ... Endocrinology